Although it’s controversial that TAK1 may act as the upstream or downstream target of AMPK50,51, our findings have confirmed that TAK1/NF-κB signaling, in line with mTORC1, is negatively regulated by AMPK in ovarian cancer cells. Here, PRKAA1 is linked to ovarian carcinoma.